Bone marrow-derived mesenchymal stem cells in repair of the injured lung

American Journal of Respiratory Cell and Molecular Biology

Volumn 33, Issue 2, 2005, Pages 145-152

  Rojas, Mauricio ^a   Xu, Jianguo ^b   Woods, Charles R ^b   Mora, Ana L ^b   Spears, Willy ^b   Roman, Jesse ^b   Brigham, Kenneth L ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Bleomycin; Lung injury; Stem cells

Indexed keywords

BLEOMYCIN; BUSULFAN; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW SUPPRESSION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFER; CONTROLLED STUDY; INFLAMMATION; LUNG FIBROSIS; LUNG INJURY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PHENOTYPE; TISSUE REPAIR; ANIMAL; BLOOD; C57BL MOUSE; CELL MOTION; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION; GENETICS; IN VITRO STUDY; INJURY; LUNG; MESENCHYMAL STEM CELL TRANSPLANTATION; PATHOLOGY; PATHOPHYSIOLOGY; PLURIPOTENT STEM CELL; SIGNAL TRANSDUCTION;

ANIMALIA;

ANIMALS; BLEOMYCIN; BONE MARROW CELLS; CELL MOVEMENT; CELL PROLIFERATION; CYTOKINES; GENE EXPRESSION; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; LUNG; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED C57BL; PLURIPOTENT STEM CELLS; PULMONARY FIBROSIS; SIGNAL TRANSDUCTION;

EID: 24344448730     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2004-0330OC     Document Type: Article

References (26)

1. Abkowitz JL, Robinson AE, Kale S, Long MW, Chen J. Mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure. Blood 2003;102:1249-1253.
2. Herzog EL, Chai L, Krause DS. Plasticity of marrow-derived stem cells. Blood 2003;102:3483-3493.
3. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276:71-74.
4. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-98.
5. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, Phinney DG. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 2003;100:8407-8411.
6. Fine A. Marrow cells as progenitors of lung tissue. Blood Cells Mol Dis 2004;32:95-96.
7. Kotton DN, Summer R, Fine A. Lung stem cells: new paradigms. Exp Hematol 2004;32:340-343.
8. Bowden DH. Unraveling pulmonary fibrosis: the bleomycin model. Lab Invest 1984;50:487-488.
9. Lasky JA, Ortiz LA, Tonthat B, Hoyle GW, Corti M, Athas G, Lungarella G, Brody A, Friedman M. Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis. Am J Physiol 1998;275:L365-L371.
10. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. "Green mice" as a source of ubiquitous green cells. FEBS Lett 1997;407:313-319.
11. Piguet PF, Collart MA, Grau GE, Kapanci Y, Vassalli P. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med 1989;170:655-663.
12. Olman MA, Simmons WL, Pollman DJ, Loftis AY, Bini A, Miller EJ, Fuller GM, Rivera KE. Polymerization of fibrinogen in murine bleomycin-induced lung injury. Am J Physiol 1996;271:L519-L526.
13. Epperly MW, Guo H, Gretton JE, Greenberger JS. Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. Am J Respir Cell Mol Biol 2003;29:213-224.
14. Kotton DN, Fine A. Derivation of lung epithelium from bone marrow cells. Cytotherapy 2003;5:169-173.
15. Bishop AE. Pulmonary epithelial stem cells. Cell Prolif 2004;37:89-96.
16. Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell 2004;116:639-648.
17. Spees JL, Olson SD, Ylostalo J, Lynch PJ, Smith J, Perry A, Peister A, Wang MY, Prockop DJ. Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Natl Acad Sci USA 2003;100:2397-2402.
18. Cho HJ, Kim HS, Lee MM, Kim DH, Yang HJ, Hur J, Hwang KK, Oh S, Choi YJ, Chae IH, et al. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation 2003;108:2918-2925.
19. Zhu J, Kaplan AM, Goud SN. Immunologic alterations in bleomycin-treated mice: role of pulmonary fibrosis in the modulation of immune responses. Am J Respir Crit Care Med 1996;153:1924-1930.
20. Hille A, Rave-Frank M, Pradier O, Damm C, Dorr W, Jackel MC, Christiansen H, Hess CF, Schmidberger H. Effect of keratinocyte growth factor on the proliferation, clonogenic capacity and colony size of human epithelial tumour cells in vitro. Int J Radiol Biol 2003;79:119-128.
21. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P. Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant 2003;7:86-88.
22. Kean LS, Manci EA, Perry J, Balkan C, Coley S, Holtzclaw D, Adams AB, Larsen CP, Hsu LL, Archer DR. Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease. Blood 2003;102:4582-4593.
23. Guo Z, Wang J, Dong Y, Adams AB, Shirasugi N, Kim O, Hart J, Newton-West M, Pearson TC, Larsen CP, et al. Long-term survival of intestinal allografts induced by costimulation blockade, busulfan and donor bone marrow infusion. Am J Transplant 2003;3:1091-1098.
24. Gibson FM, Andrews CM, Diamanti P, Rizzo S, Macharia G, Gordon-Smith EC, Williams T, Turton J. A new model of busulphan-induced chronic bone marrow aplasia in the female BALB/c mouse. Int J Exp Pathol 2003;84:31-48.
25. Kotton DN, Ma BY, Cardoso WV, Sanderson EA, Summer RS, Williams MC, Fine A. Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development 2001;128:5181-5188.
26. Hirohata S, Yanagida T, Tomita T, Yoshikawa H, Ochi T. Bone marrow CD34+ progenitor cells stimulated with stem cell factor and GM-CSF have the capacity to activate IgD- B cells through direct cellular interaction. J Leukoc Biol 2002;71:987-995.